Equities

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)84.99
  • Today's Change-0.70 / -0.82%
  • Shares traded464.51k
  • 1 Year change+43.03%
  • Beta0.9547
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(140)(256)(284)
Depreciation/depletion0.530.660.53
Non-Cash items454430
Cash taxes paid, supplemental0.160.010.01
Cash interest paid, supplemental------
Changes in working capital(30)(58)(6.35)
Total cash from operations(124)(270)(260)
INVESTING
Capital expenditures(0.27)(0.78)(0.33)
Other investing and cash flow items, total106(128)281
Total cash from investing106(128)280
FINANCING
Financing cash flow items------
Total cash dividends paid------
Issuance (retirement) of stock, net1845512
Issuance (retirement) of debt, net------
Total cash from financing1845512
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(0.85)5732
Net cash-begin balance/reserved for future use1509461
Net cash-end balance/reserved for future use15015094
SUPPLEMENTAL INCOME
Depreciation, supplemental0.530.660.53
Cash interest paid, supplemental------
Cash taxes paid, supplemental0.160.010.01
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.